More articles from Drug Discovery and Translational Medicine

You have access
Characterization of 2-[[4-Fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a Novel Positive Allosteric Modulator of the α₇ Nicotinic Acetylcholine Receptor
Theo Dinklo, Hamdy Shaban, Jan Willem Thuring, Hilde Lavreysen, Karen E. Stevens, Lijun Zheng, Claire Mackie, Christopher Grantham, Ine Vandenberk, Greet Meulders, Luc Peeters, Hanne Verachtert, Erik De Prins and Anne S. J. Lesage

Journal of Pharmacology and Experimental Therapeutics February 2011, 336 (2) 560-574; DOI: https://doi.org/10.1124/jpet.110.173245
You have access
Pharmacological Characterization of KLYP961, a Dual Inhibitor of Inducible and Neuronal Nitric-Oxide Synthases
Kent T. Symons, Phan M. Nguyen, Mark E. Massari, John V. Anzola, Lena M. Staszewski, Li Wang, Nahid Yazdani, Steven Dorow, Jerry Muhammad, Marciano Sablad, Natasha Rozenkrants, Celine Bonefous, Joseph E. Payne, Peter J. Rix, Andrew K. Shiau, Stewart A. Noble, Nicholas D. Smith, Christian A. Hassig, Yan Zhang and Tadimeti S. Rao

Journal of Pharmacology and Experimental Therapeutics February 2011, 336 (2) 468-478; DOI: https://doi.org/10.1124/jpet.110.172817
You have access
The Fate and Function of Therapeutic Antiaddiction Monoclonal Antibodies across the Reproductive Cycle of Rats
Jonathan J. Hubbard, Elizabeth M. Laurenzana, D. Keith Williams, W. Brooks Gentry and S. Michael Owens

Journal of Pharmacology and Experimental Therapeutics February 2011, 336 (2) 414-422; DOI: https://doi.org/10.1124/jpet.110.175083
You have access
The Nitric Oxide Prodrug JS-K Is Effective against Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo: Involvement of Reactive Oxygen Species
Anna E. Maciag, Harinath Chakrapani, Joseph E. Saavedra, Nicole L. Morris, Ryan J. Holland, Ken M. Kosak, Paul J. Shami, Lucy M. Anderson and Larry K. Keefer

Journal of Pharmacology and Experimental Therapeutics February 2011, 336 (2) 313-320; DOI: https://doi.org/10.1124/jpet.110.174904
You have access
Pharmacological Characterization of Diethyl-2-({3-dimethylcarbamoyl-4-[(4′-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein
Yasuko Mera, Naoya Odani, Takashi Kawai, Takahiro Hata, Masahiro Suzuki, Atsushi Hagiwara, Takeo Katsushima and Makoto Kakutani

Journal of Pharmacology and Experimental Therapeutics February 2011, 336 (2) 321-327; DOI: https://doi.org/10.1124/jpet.110.173807
You have access
Reducing Undesirable Hepatic Clearance of a Tumor-Targeted Vinca Alkaloid via Novel Saccharopeptidic Modifications
Christopher P. Leamon, Joseph A. Reddy, Patrick J. Klein, Iontcho R. Vlahov, Ryan Dorton, Alicia Bloomfield, Melissa Nelson, Elaine Westrick, Nikki Parker, Kristen Bruna, Marilynn Vetzel, Mark Gehrke, Jeffrey S. Nicoson, Richard A. Messmann, Patricia M. LoRusso and Edward A. Sausville

Journal of Pharmacology and Experimental Therapeutics February 2011, 336 (2) 336-343; DOI: https://doi.org/10.1124/jpet.110.175109
You have access
Bis-Halogen-Anthraniloyl-Substituted Nucleoside 5′-Triphosphates as Potent and Selective Inhibitors of Bordetella pertussis Adenylyl Cyclase Toxin
Jens Geduhn, Stefan Dove, Yuequan Shen, Wei-Jen Tang, Burkhard König and Roland Seifert

Journal of Pharmacology and Experimental Therapeutics January 2011, 336 (1) 104-115; DOI: https://doi.org/10.1124/jpet.110.174219
You have access
N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a Novel Metabotropic Glutamate 2 Potentiator with Potential Anxiolytic/Antidepressant Properties: In Vivo Profiling Suggests a Link between Behavioral and Central Nervous System Neurochemical Changes
Matthew J. Fell, Jeffrey M. Witkin, Julie F. Falcone, Jason S. Katner, Kenneth W. Perry, John Hart, Linda Rorick-Kehn, Carl D. Overshiner, Kurt Rasmussen, Stephen F. Chaney, Mark J. Benvenga, Xia Li, Deanna L. Marlow, Linda K. Thompson, Susan K. Luecke, Keith A. Wafford, Wesley F. Seidel, Dale M. Edgar, Anne T. Quets, Christian C. Felder, XuShan Wang, Beverly A. Heinz, Alexander Nikolayev, Ming-Shang Kuo, Daniel Mayhugh, Albert Khilevich, Deyi Zhang, Philip J. Ebert, James A. Eckstein, Bradley L. Ackermann, Steven P. Swanson, John T. Catlow, Robert A. Dean, Kimberley Jackson, Sitra Tauscher-Wisniewski, Gerard J. Marek, Jeffrey M. Schkeryantz and Kjell A. Svensson

Journal of Pharmacology and Experimental Therapeutics January 2011, 336 (1) 165-177; DOI: https://doi.org/10.1124/jpet.110.172957
You have access
RG3487, a Novel Nicotinic α7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents
Tanya L. Wallace, Patrick M. Callahan, Ashok Tehim, Daniel Bertrand, Geoffrey Tombaugh, Shaojie Wang, Walter Xie, Wayne B. Rowe, Voon Ong, Elizabeth Graham, Alvin V. Terry, Joshua S. Rodefer, Brian Herbert, Michael Murray, Richard Porter, Luca Santarelli and David A. Lowe

Journal of Pharmacology and Experimental Therapeutics January 2011, 336 (1) 242-253; DOI: https://doi.org/10.1124/jpet.110.171892
You have access
FYX-051: A Novel and Potent Hybrid-Type Inhibitor of Xanthine Oxidoreductase
Koji Matsumoto, Ken Okamoto, Naoki Ashizawa and Takeshi Nishino

Journal of Pharmacology and Experimental Therapeutics January 2011, 336 (1) 95-103; DOI: https://doi.org/10.1124/jpet.110.174540

Main menu

User menu

Search

More articles from Drug Discovery and Translational Medicine

Pages

Navigate

More Information

ASPET's Other Journals